Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-014714
Filing Date
2022-06-09
Accepted
2022-06-09 20:13:42
Documents
1
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5608
  Complete submission text file 0001437749-22-014714.txt   7372
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Issuer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DAMONMILL SQUARE SUITE 6A CONCORD MA 01742
Business Address
Geffken Daniel E. (Reporting) CIK: 0001314756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39290 | Film No.: 221007382